Home | All results_reference

[RDF data]
Results Reference #1045

Resource URI: http://static.linkedct.org/resource/results_reference/1045
linkedct:citation Li T, Christos P, Sparano JA, et al.: Phase II study of the farnesyl transferase inhibitor tipifarnib plus fulvestrant in postmenopausal patients with hormone receptor-positive breast cancer: New York Cancer Consortium trial P6205. [Abstract] J Clin Oncol 25 (Suppl 18): A-1037, 41s, 2007.
rdfs:label Results Reference #1045
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00082810>
linkedct:results_reference_id 1045 (xsd:int)
rdf:type linkedct:results_reference